ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00036374
Recruitment Status : Completed
First Posted : May 10, 2002
Last Update Posted : May 17, 2011
Sponsor:
Information provided by:
Centocor, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : December 2006
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):